# A Study to Assess the Relative Bioavailability of Oral Tavapadon in Healthy Adult Participants

> **NCT06895356** · PHASE1 · COMPLETED · sponsor: **AbbVie** · enrollment: 83 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Tavapadon

## Key facts

- **NCT ID:** NCT06895356
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-26
- **Primary completion:** 2025-06-16
- **Final completion:** 2025-06-16
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06895356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06895356, "A Study to Assess the Relative Bioavailability of Oral Tavapadon in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06895356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*